Ellevest, Inc. Galapagos Nv Transaction History

Ellevest, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Oct 19, 2021	SELL	$52.17 - $70.2 $2,347 - $3,159	-45 Closed	0 $0
Q2 2021 Jul 13, 2021	BUY	$68.86 - $83.34 $1,859 - $2,250	27 Added 150.0%	45 $3,000
Q1 2021 May 03, 2021	SELL	$76.15 - $111.94 $9,290 - $13,656	-122 Reduced 87.14%	18 $1,000
Q4 2020 Feb 04, 2021	BUY	$96.85 - $148.25 $11,428 - $17,493	118 Added 536.36%	140 $14,000
Q3 2020 Oct 26, 2020	BUY	$122.47 - $213.56 $1,102 - $1,922	9 Added 69.23%	22 $3,000
Q2 2020 Jul 06, 2020	SELL	$185.52 - $231.25 $371 - $462	-2 Reduced 13.33%	13 $3,000
Q1 2020 Apr 13, 2020	BUY	$143.0 - $274.03 $2,145 - $4,110	15 New	15 $3,000

12.3M

69.1K

42.7K

Ticker GLPG
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,835,500
Market Cap $1.9B
Description
Galapagos NV, an integrated biopharmaceutical company, engages in the discovery, development, and commercialization of various medicines for high unmet medical need. Its pipeline products include filgotinib, a JAK1 inhibitor that is in various phases of clinical trials for the treatment of rheumatoid arthritis, Crohn's disease, ulcerative coliti...

Get notified when there are updates to the investment portfolio of Ellevest, Inc., based on Form 13F filings with the SEC.

Stay updated on Ellevest, Inc. with notifications on news.